Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment.
暂无分享,去创建一个
Kevin Gardner | Irene Collins | Idalia Montano | K. Gardner | E. Kawasaki | A. De Siervi | C. Haggerty | W. Butscher | J. Merchant | James L. Smith | I. Collins | Ernest Kawasaki | Juanita L Merchant | Cynthia M Haggerty | Adriana De Siervi | M. McNutt | W. Freebern | Markey C McNutt | James L Smith | Wendy J Freebern | Wayne G Butscher | Inna Dzekunova | David W Petersen | David Petersen | Inna Dzekunova | I. Montano
[1] G. Condorelli,et al. Human p300 Protein Is a Coactivator for the Transcription Factor MyoD (*) , 1996, The Journal of Biological Chemistry.
[2] T. Volkert,et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.
[3] K. Gardner,et al. Cross-Regulation of T Cell Growth Factor Expression by p53 and the Tax Oncogene , 2002, The Journal of Immunology.
[4] G. Firestone,et al. Role of the CCAAT/Enhancer Binding Protein-α Transcription Factor in the Glucocorticoid Stimulation of p21 waf1/cip1 Gene Promoter Activity in Growth-arrested Rat Hepatoma Cells* , 1998, The Journal of Biological Chemistry.
[5] P. Pandolfi,et al. Mzf1 controls cell proliferation and tumorigenesis. , 2001, Genes & development.
[6] L. Pennacchio,et al. Genomic strategies to identify mammalian regulatory sequences , 2001, Nature Reviews Genetics.
[7] G. Stormo,et al. Identification of a novel cis-regulatory element involved in the heat shock response in Caenorhabditis elegans using microarray gene expression and computational methods. , 2002, Genome research.
[8] D. Pe’er,et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data , 2003, Nature Genetics.
[9] Carlos Caldas,et al. Mutations truncating the EP300 acetylase in human cancers , 2000, Nature Genetics.
[10] Tetsuo Yoshida,et al. Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase. , 1996, The Journal of antibiotics.
[11] K. Gardner,et al. Targeting Combinatorial Transcriptional Complex Assembly at Specific Modules within the Interleukin-2 Promoter by the Immunosuppressant SB203580* , 2003, Journal of Biological Chemistry.
[12] S. Rafii,et al. Splitting vessels: Keeping lymph apart from blood , 2003, Nature Medicine.
[13] G. Orphanides,et al. A Unified Theory of Gene Expression , 2002, Cell.
[14] Richard A Young,et al. Deciphering gene expression regulatory networks. , 2002, Current opinion in genetics & development.
[15] Xiao-Fan Wang,et al. Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 WAF1/CIP1 in Human Prostate Carcinoma Cells* , 1998, The Journal of Biological Chemistry.
[16] Interaction and functional collaboration of p300 and C/EBPbeta. , 1997, Molecular and cellular biology.
[17] Ash A. Alizadeh,et al. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Merchant,et al. Transcription Factor ZBP-89 Cooperates with Histone Acetyltransferase p300 during Butyrate Activation of p21 waf1 Transcription in Human Cells* , 2000, The Journal of Biological Chemistry.
[19] B. Howard,et al. The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.
[20] J. Fargnoli,et al. Isolation and characterization of the hamster gadd153 gene. Activation of promoter activity by agents that damage DNA. , 1990, The Journal of biological chemistry.
[21] T. Werner. Computer-Assisted Analysis of Transcription Control Regions , 2000 .
[22] Chi V. Dang,et al. A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Goodman,et al. CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.
[24] A. Michelson. Deciphering genetic regulatory codes: A challenge for functional genomics , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Rivera,et al. A Role for CREB Binding Protein and p300 Transcriptional Coactivators in Ets-1 Transactivation Functions , 1998, Molecular and Cellular Biology.
[26] J. T. Kadonaga,et al. Biochemical Analysis of Distinct Activation Functions in p300 That Enhance Transcription Initiation with Chromatin Templates , 1999, Molecular and Cellular Biology.
[27] Tim Hui-Ming Huang,et al. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. , 2002, Genes & development.
[28] David Botstein,et al. Promoter-specific binding of Rap1 revealed by genome-wide maps of protein–DNA association , 2001, Nature Genetics.
[29] R. Tjian,et al. Transcription regulation and animal diversity , 2003, Nature.
[30] J. Fickett,et al. Identification of regulatory regions which confer muscle-specific gene expression. , 1998, Journal of molecular biology.
[31] R. Kingston,et al. Cooperation between Complexes that Regulate Chromatin Structure and Transcription , 2002, Cell.
[32] Joe W. Gray,et al. The Molecular Basis of Cancer , 1985 .
[33] Thomas E. Royce,et al. Distribution of NF-κB-binding sites across human chromosome 22 , 2003, Proceedings of the National Academy of Sciences of the United States of America.